Try our Advanced Search for more refined results

Perrigo Company v. United States of America

  1. October 11, 2019

    Court Allows $163M Perrigo-US Tax Dispute To Continue

    A Michigan federal court on Friday denied both the U.S. and Perrigo summary judgment in their $163 million international tax dispute over a Perrigo offshore subsidiary's heartburn drug contract.

  2. June 06, 2019

    Perrigo Set Up Israeli Co. To Skip Tax, US Says In $163M Row

    Perrigo created an Israeli subsidiary in 2006 as an "empty box," and the assignment of a heartburn drug contract to the subsidiary should be disregarded in a $163 million tax dispute, the U.S. has told a Michigan federal court.

  3. May 16, 2019

    Perrigo Says IRS Can't Undo Tax Structure Approval In $163M Row

    Generic drug manufacturer Perrigo told a Michigan federal court that the Internal Revenue Service shouldn't be able to reverse previous approval of the company's international tax structure in its $163.4 million international tax dispute.

  4. April 16, 2019

    No Settlement In Sight In Perrigo's $163M Tax Row With U.S.

    The U.S. government and Irish-registered generic pharmaceutical maker Perrigo Co. have failed to resolve a $163.4 million tax dispute during a settlement conference, according to minutes of the proceeding in a Michigan federal court.

  5. January 22, 2019

    Judge Nixes Perrigo's Bid For IRS Report In $163M Tax Row

    A Michigan federal judge has denied pharmaceutical company Perrigo Co.'s efforts to force the U.S. to produce an Internal Revenue Service economist's report in a $163.4 million tax dispute.

  6. December 17, 2018

    Perrigo Wants IRS Economist's Audit Report In $163.5M Row

    Generic pharmaceutical giant Perrigo Co. has demanded in a Michigan federal court that the U.S. government turn over an economist's report produced during an Internal Revenue Service audit that led to a $163.5 million tax-refund dispute.

  7. December 06, 2018

    Feds Blocked Again From Deposing Israelis In $163M Tax Row

    The government cannot depose two Israeli executives about their company's business with U.S. drugmaker Perrigo in a $163.5 million tax dispute, with a Michigan federal court again ruling Thursday it would be too expensive.

  8. November 14, 2018

    Israeli Docs Unnecessary In $163.5M Tax Suit, Perrigo Says

    The U.S. government's narrowed requests for Israeli court documents and depositions of two Israeli executives in a $163.5 million tax refund dispute are unnecessary and will yield duplicative evidence, Perrigo Co. has told a Michigan federal court.

  9. October 31, 2018

    US Narrows Bid For Israeli Court Docs In $163.5M Tax Row

    The Internal Revenue Service has narrowed its bid to obtain documents from Israeli courts in a $163.5 million tax dispute with a generic pharmaceutical company after a federal judge rejected an earlier attempt this year as being too broad.

  10. February 21, 2018

    Feds Can't Get Israeli Court Info In $163M Perrigo Tax Row

    A Michigan federal judge refused on Wednesday to ask Israeli courts for information the U.S. government is seeking in a $163.5 million tax fight against a company that domestically distributed heartburn drugs manufactured in Israel in partnership with Perrigo Co., saying such requests would unnecessarily add to the time, cost and complexity of the case.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!